Regis Technologies Inc.
Regis Technologies Inc.
News Article | May 9, 2017
For additional information or to register for CPhI North America and InformEx 2017, please visit: www.cphinorthamerica.com or www.informex.com. Registration to either event offers full access to both exhibition floors. While more than 630 leading solution providers will populate the exhibition floor, the following are some of the highlights: Aavis Pharmaceuticals Inc. (booth 3210) - Has established a brand new facility and will serve as a CDMO offering end-to-end pharmaceutical development and manufacturing solutions. Capabilities as an integrated service provider and experience with a range of technologies enables ability to serve both innovator and generic companies worldwide. ACIC (booth 2431) - A full-service pharmaceutical company providing API, finished formulations and pharmaceutical machinery. The ACIC service relationship is a very flexible one structuring custom services to meet client needs. Alphora Research Inc. (booth 2138) - Provides API technology development and scale-up services for complex small molecules, including niche APIs, high potency and cytotoxic compounds. Our services cover IND enabling development, phase II & III, and commercial manufacturing of niche APIs. Amcor Flexibles (booth 3105) - Focused on improving sterile fluid delivery with barrier embedded primary containers which remove steps at critical points-of-care, maintain product integrity, and improve product stability. Anguil Environmental Systems (booth 940) - Air pollution control technologies and techniques applied to the pharmaceutical and chemical processing industries for regulatory compliance. Aptar Pharma (booth 3102) – Offering a breakthrough Ophthalmic Squeeze Dispenser, the first and only FDA-reviewed multi-dose delivery system to handle preservative-free eye treatment formulations with metal-free pathways. B&W Tek (booth 3025) - The i-Raman Pro ST is a new portable Raman system that can see through opaque packaging to identify the material inside. Bausch Advanced Technology Group (booth 3114) - Triple Container Filling & Stoppering Machine Type 535 is a flexible modular processing machine featuring three different filling systems: rotary piston pump, peristaltic pump and time pressure on one platform to offer the most flexibility for customers. Baxter BioPharma Solutions (booth 2454) - Baxter's BioPharma Solutions facility in Bloomington, Indiana, was recently recognized as the "Best Contract Manufacturing Organization" at the 2017 Annual Vaccine Industry Excellence (ViE) Awards. Benzo Chem Industries PVT. LTD. (booth 2241) - Manufacturers of pharmaceutical and agro intermediates with four ISO compliant plants. An additional GMP plant will begin operations in August 2017. Bormioli Rocco (booth 3112) - A wide range of Type I Glass, Amber and Flint, produced in a pharma approved environment, following the highest quality standards. Bosch Packaging Technology (booth 3201) - The Solidlab 2 is a multifunctional system capable of granulating, drying and coating with flexible batch sizes from 0.25 to 12 kilograms. BUCHI Corporation (booth 1252) - Introducing the first freeze dryer with unlimited capacity for continuous freeze drying. The Lyovapor L-300 offers two alternately working condensers that automatically clean while freezing down to -105°C. Capricorn Life Sciences (booth 3001) – Out-licensing food supplements, medical devices and pharmaceutical OTC's under brand names or private label. ChemicalInfo (booth 2240) - Directory of World Chemical Producers (DWCP) connects buyers and sellers of chemicals and pharmaceuticals with global producer details including contact and product information. Chemo Dynamics, Inc. (booth 938) - U.S. based CRO/CMO with cGMP facility providing pharmaceutical and biopharmaceutical contract research, custom synthesis, analytical service and small quantity manufacturing. CordenPharma (booth 2160) - Offers development & manufacturing expertise across specialized technology platforms from regulated raw materials through intermediates, APIs, drug product manufacturing & packaging. CurTec (booth 2231) - Presenting Pharma Grade Packo, screw top jars that have been tested according to European and U.S. Pharmacopoeia and are suitable as primary packaging for pharmaceuticals. DATWYLER (booth 3204) - Offering a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. EAS Consulting Group, LLC (booth 2551) - Provider of FDA regulatory consulting services, with more than 50 years of experience. Capabilities include performing cGMP audits and mock FDA inspections, quality system implementation and remediation, product development and regulatory strategies, to submissions, filings, registrations, assistance with imports and acting as an U.S. Agent. EMBOCAPS by Suheung (booth 2733) - Introducing a premium empty capsule product line - EMBOCAPS VG ALPHA. No gelling agents, pH independent disintegration profile, and superior machinability. Erawat Pharma Limited (booth 3126) - An ultra-modern facility brings you hard capsules in easy fitting, sticky free, liquid filling, metallic , preservative and SLS free varieties driven by best standards of quality and consumer satisfaction. FabriChem, Inc. (booth 2121) - D-Galactose from plant origin, L-Tyrosine and L-Leucine from corn protein (vegetable origin) for use in bio pharmaceuticals & cell culture. 1, 2, 6 Hexane triol for moisturizing agent in creams, Guanidine hydrochloride for biopharmaceuticals, Dipicolinic Acid & Alpha Picolinic Acid. FAR Chemical, Inc. (booth 1234) - Manufacturer of fine and specialty chemicals sold to a variety of industries and applications including: pharmaceutical reagents and intermediates, advanced polymers, organometallics, silane & bromine chemistries, and structural composites. Flamma (booth 2344) - Flamma will open its cGMP workshop at Flamma Honkai (Dalian, China) in June providing customers a trusted partner to integrate projects from Italy to China. Also, project managers have been added in Italy and China in order to better serve customers, new capabilities have been added and land has been acquired for company growth and expansion. Fresenius Kabi Product Partnering (booth 2938) - The contract manufacturing platform of Fresenius Kabi offers manufacturing expertise of more than 20 facilities worldwide. A full range of services for both fill and finish of solutions are provided along with emulsions in ampoules, vials, bottles, IV-bags, and pre-filled syringes. Frontida BioPharm, Inc. (booth 2865) - Proprietary AdaptDoseTM encapsulation platform and DuraGran® coated granule technology provides speed, precision, flexibility and cost-savings in the product development through commercialization process. Large U.S., high-capacity facility, with expertise in controlled release granules, fluid bed operations, solvent processing, DEA controlled substances, HPAPI and nanoparticle milling. Fuji Chemical Industries Co., Ltd. (booth 2354) - Sales and marketing of unique specialty excipients, and the contract manufacturing and development of solid dispersion processing with closed spray driers. GBR - Global Business Reports (booth 3261) - Launching the U.S. Pharmaceuticals 2017 book which provides in-depth global analysis and up-to-date insights into all aspects of the oil and gas, pharmaceuticals, chemicals, energy, aerospace and mining industries. Grifols (booth 3037) - Premixed solutions ready-to-use in PP bag deliver a fixed dose in 50 mL to 1 L ensuring accurate delivery of the drug to the patient. Groupe PARIMA (booth 2807) - A CDMO specialized in the development and manufacturing of liquids, suspensions, semi-solids and sprays. GSK Contract Manufacturing (booth 3111) - Offering a fully integrated supply chain solution to the pharma/biopharm industry with FDA & EMA approved, multi-product facilities along with providing multiple services for Consumer and OTC markets. Haemopharm Healthcare S.r.l. (booth 3124) - Showing the first needle-free technology that not only enables the use of the syringe without the needle, but also provides a hermetic closure, minimizing contaminations and increasing safety. This patented needle-free technology has been applied to both vials (NIV®) and bags (NIP®). Halo Pharma (booth 3132) - Delivering pediatric products from clinical through commercialization (Microtablets, Stickpacks, Granules for Suspensions, Oral Solutions/Suspensions). Recognized as a Pediatric Center of Excellence. Heraeus (booth 2441) - Specializes in the production of generic pharmaceutical ingredients and is the worldwide leading supplier of Platinum hAPIs. International Process Plants (IPP) (booth 1245) - Used equipment offers the highest value rating possible by offering equipment for < 50% off new with delivery times in days instead of months. I.R.A. Istituto Ricerche Applicate (booth 2257) - Linear and cross linked hyaluronic acid for aesthetic and orthopedic fillers. Kingchem Life Science LLC (booth 1324) – Offers complex chemistry products, processes and capabilities including: Boronic acids, heterocyclic chemistry, halogenations, fluorinated compounds including trifluoromethyl and difluoroderivatives, nucleophilic fluorination, cyogenic chemistry, isocyanates, large Scale HF and KF chemistry. Laurus Labs Limited (booth 1100) - Laurus Generics has combined innovation with efficiency by developing cost effective processes to develop an in-house range of APIs and related intermediates. Laurus Synthesis strives to be recognized as the definitive example of "East Meets West" drug development by combining unparalleled front-end process chemistry expertise in both the U.S. and India with world-class back-end API manufacturing resources. LF of America Corp. (booth 3106) - Contract manufacturing, packaging manufacturing and contract filling of liquid sterile solutions in unit-dose delivery systems. LGC Standards (booth 3241) - LGC Standards is an ISO Guide 34, ISO/IEC 17025 accredited manufacturer offering more than 4,000 pharmaceutical reference standards including: impurities, APIs, excipients and primary standards LGM Pharma (booth 2501) - Provides comprehensive cGMP API sourcing solutions backed by complete technical and regulatory capabilities to a diverse array of U.S. pharmaceutical companies. Macco Organiques, s.r.o. (booth 2554) - cGMP (GMP, Q7 certified), well recognized production and supplier of inorganic and organic mineral salts for the pharmaceutical and biopharmaceutical industry, infant formulas producers, food and beverage manufacturers. ManageArtworks (booth 3235) - Packaging artwork management software that helps life science companies manage the processes, text matter, design and other components of a packaging artwork via an electronic workflow. As a CFR Part 11 compliant system, it offers transparency with effortless tracking, audit trails, alerts and dashboards. Novasep (booth 1456) - Announced that its new €11M antibody-drug conjugate bioconjugation facility is now operational to support our pharmaceutical customers in developing the latest innovative treatments against cancer. Ompi - Stevanato Group (booth 3207) - Developed a new fully passive and fully customizable, integrated needlestick protection - the Ompi EZ-fill® Integrated Safety System (ISS). It provides automatic shield retraction in an elegant and highly customizable way. PCI Synthesis (booth 2128) - Pharmaceutical development CMO based in Newburyport, MA is the largest small molecule drug substance manufacturer in the New England area. PCI is also a commercial manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products for the medical device industry. Polpharma Pharmaceutical Works (booth 2250) - A cGMP-compliant and a FDA-approved European producer of API, providing a wide-range of services including FDF out-licensing and supply and contract manufacturing services. PolyCine GmbH (booth 3223) - Global leader for the packaging of IV solution bags providing: standard films and tubes, peelable films for multi-chamber bags, special films for lipids, gas barrier films, overwrap films, filling & transfer tubes, special modified granules & compounds and hot stamping foil. Polycrystalline (booth 2253) - With the mission of "Crystallization by Design," providing services for the research and development of highly potent API and controlled substances/narcotics. Polycrystalline shares protocols, methods, and raw data customizing activities to meet specifics clients' goals, timeframes and budget. PolyPeptide Group (booth 924) - A world leading GMP peptide (CDMO) with six facilities worldwide in Belgium, France, India, Sweden, San Diego and Torrance. Potasse et Produits Chimiques (booth 1034) - Extensive technical experience for bromination, hydrobromination and related technologies. Brominated compounds are widely used in specialty chemicals, in pharmaceuticals, agrochemicals, polymer additives, and cosmetics products as intermediates. PQE US, Inc. (booth 3130) - Global consulting firm specializing in the life sciences industry. Provides global support in: data integrity assurance, computer system validation, qualification and engineering, quality assurance and compliance and regulatory affairs. Pressure Chemical Co. (booth 1444) - Providing pilot, scale-up, and custom contract manufacturing services in a flexible facility with highly experienced project leaders and operations; enabling clients to: gather process information, reduce startup capital, and bridge the gap beyond current capabilities. Q Laboratories, Inc. (booth 3134) - Provides microbiology, analytical chemistry and research & development laboratory services and helps companies worldwide meet the level of excellence they demand to produce safe, high-quality products. Qosina Corporation (booth 3236) - Purchasing components from Qosina save you both time and money by eliminating tool costs and providing immediate delivery of in-stock solutions. Qualicaps (booth 2913) - Quali-V® capsules are plant-based alternative to gelatin capsules designed to meet the demanding requirements of the pharmaceutical industry. R-Pharm Germany GmbH (booth 3135) - CDMO providing manufacturing, packaging, serialization, formulation, scale-up, product-launch, analytics and stability, as well as high potency API manufacturing. REACHLaw Ltd. (booth 1052) - Offers chemical regulatory compliance helping clients gain market access for their chemical products. Services include: REACH Only Representation, REACH Registrations, REACH Authorisation, REACH Out-Tasking, Advocacy Services, Global Notifications and Consultancy Services. Regis Technologies Inc. (booth 1124) – Utilizing analytical and synthesis expertise, offers a complete structure elucidation package to support IND and NDA filings. Reliance Label Solutions (booth 1013) - GHS, BS 5609 and IMDG certified compliance labeling solutions via the www.theghsstore.com. Rohner Inc. (booth 1151) - This Swiss custom manufacturer will be unveiling their new portfolio of Multi-Customer Products that utilize their core competencies. Roquette (booth 2829) - Features new product offerings that are low endotoxin, multi-compendial grade materials for cell culture and biologic drug formulations. Sabin Metal Corporation (booth 1254) - Provides worldwide customers with logistical support, precious metal financial services, pre-reclaim kilning and safe, accurate and responsible processing, sampling and refining of PM-bearing catalysts. Senn Chemicals AG (booth 2142) - Operates cGMP and ISO certified facilities specializing in the production of peptides and amino acid derivatives. Contract manufacturer that provides the pharmaceutical and cosmetic industry with customized products and individual solutions starting from small scale for R&D, process development, scale-up to commercial production. SK Life Science Inc. (booth 2051) - A global life sciences company known for its presence in custom chemical development, advanced intermediates and active pharmaceutical ingredient (API) manufacturing including a continuous flow process for low temperature and high pressure reaction. Symbiotica Specialty Ingredients SDN. BHD. (booth 2365) - Malaysian manufacturer of steroids with ICH Q7A GMP certification. The site was successfully inspected by the U.S. FDA in 2014 and have filed 8 U.S. DMFs: hydrocortisone valerate, clobetasol propionate, mometasone furoate, betamethasone dipropionate, betamethasone valerate, dexamethasone sodium phosphate, exemestane, halobetasol propionate. Takasago International Corporation (booth 1200) - Possesses Nobel Prize winning technology including commercial experience in continuous flow manufacturing on tonne scale. Facility is FDA Inspected. TCG Lifesciences (booth 943) - Since 2001 TCG Lifesciences, a leading CDMO, offers discovery chemistry and biology services, process development, scale-up, and cGMP manufacturing with >700 highly trained scientists and 3 facilities in Kolkata and Hyderabad. Tergus Pharma (booth 2737) - A full-service topical pharmaceutical research, development, testing and manufacturing company that has been an industry leader for more than 20 years with a state-of-the-art facility in Durham, North Carolina. "Think Topical. Think Tergus." Toronto Research Chemicals (booth 2430) - Extensive product base of 90,000+ bio-chemicals manufactured and used by more than 15,000 researchers and companies in more than 100 countries worldwide. UNIPHARMA, LLC (booth 3043) - Features innovative blow-fill-seal packaging solutions: unit dose, fill seal, liquid stickpacks and conventional filling. Both contract manufacturing and private label products in a FDA compliant, GMP facility. VanDeMark Chemical Inc. (booth 1212) - Provides phosgene chemistry for many markets including pharma, agro, personal care, coatings, sealants & adhesives, plastics, polymers, etc. Ward/Kraft, Inc. (booth 941) - Kansas-based, print manufacturer specializing in the production of forms, labels and plastic products offering GHS and BS5609 section 2 & 3 certified labels. Wego Chemical Group (booth 1027) - Triflic acid and Triflic anhydride have long been used for a number of important reactions in pharmaceutical chemistry and asymmetric synthesis. Now they are more economical than ever thanks to world class production and global distribution. WeylChem (booth 1034) - Offers custom tolling and manufacturing services, as well as advanced intermediate products for the specialty and pharmaceutical markets. To see a full list of exhibitors and the floor plan, click here. Participate in the Epicenter of Pharmaceutical and Specialty Chemical Innovation CPhI North America and InformEx 2017 attendees have access to the sold-out expo floor, featuring more than 630 companies across the complete pharma supply chain, as well as show floor programming, networking events, and much more. With its unique blend of unprecedented global influence and the infrastructure to advance relationships between buyers and sellers, CPhI North America and InformEx will provide a marketplace of solutions and ideas unlike any other. Not yet registered for CPhI North America or InformEx? Free registration ends May 15 - register now! CPhI drives growth and innovation at every step of the global pharmaceutical supply chain, from drug discovery to finished dosage. Through exhibitions, conferences, and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities, and expand the global market. CPhI hosts events across Europe, Asia, and now North America, and co-locates with ICSE for contract services; P-MEC for machinery, equipment, and technology; InnoPack for pharmaceutical packaging; and BioPh for biopharma. CPhI provides an online buyer and supplier directory at CPhI-Online.com. UBM Americas, a part of UBM plc, delivers events and marketing services in the fashion technology, licensing, advanced manufacturing, automotive and powersports, healthcare, veterinary, and pharmaceutical industries, among others. Through a range of aligned interactive environments, both physical and digital, UBM Americas increases business effectiveness for customers and audiences through meaningful experiences, knowledge, and connections. The division also includes UBM Brazil's market-leading events in construction, cargo transportation, logistics and international trade, and agricultural production; and UBM Mexico's construction, advanced manufacturing, and hospitality services shows. For more information, visit: www.ubmamericas.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/leading-pharmaceutical-and-specialty-chemical-solution-providers-highlight-innovation-at-cphi-north-america-and-informex-2017-300454063.html
News Article | May 4, 2017
Global Chromatography Solvents Market, By Type (Polar, Non Polar), By Technology (LCMS, HPLC, UHPLC), By Application (Analytical Chromatography, Preparative Chromatography), By End-User (Pharmaceutical, Biotechnology Industry, Academics and Research, Environmental, Cosmetic Industry, Food and Beverage), By Geography (North America, Europe, APAC, Latin America, Rest of the World) Industry Trends and Forecast to 2024 Dallas, TX, May 04, 2017 --( The global chromatography solvents market is segmented based on product type, technology application, end-user and geography. Request for sample pages: http://databridgemarketresearch.com/reports/global-chromatography-solvents-market/ Based on type the chromatography solvents market is segmented into Polar and Non Polar. On the basis of technology the market is segmented into LCMS, HPLC, and UHPLC. Based on application the market is segmented into Analytical Chromatography, and Preparative Chromatography. On the basis of end-user the market is segmented into Pharmaceutical, Biotechnology Industry, Academics and Research, Environmental, Cosmetic Industry, and Food and Beverage. Based on geographies the market covered in this reports are North America, Europe Asia Pacific and Rest of the World. The major countries covered in this report are U.S., Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil. Read more: http://databridgemarketresearch.com/global-chromatography-solvents-market-expected-grow-cagr-10-1/ The global players operating in this market are EMD-Millipore, Avantor Performance Materials, Tedia Company, Inc., Regis Technologies, Inc., Thermo Fisher Scientific, Inc., VWR International, and Qualikems Fine Chem Pvt. Ltd. among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, May 04, 2017 --( PR.com )-- The market for chromatography solvents market is expected to reach USD 3.6 billion by 2024, from USD 1.7 billion in 2016, at a CAGR of 10.1% during the forecast period 2017-2024. The market report contains actual calculation year for the report in 2016, while the historic data is for 2015 and the forecast period is still 2024.The global chromatography solvents market is segmented based on product type, technology application, end-user and geography.Request for sample pages: http://databridgemarketresearch.com/reports/global-chromatography-solvents-market/Based on type the chromatography solvents market is segmented into Polar and Non Polar.On the basis of technology the market is segmented into LCMS, HPLC, and UHPLC.Based on application the market is segmented into Analytical Chromatography, and Preparative Chromatography.On the basis of end-user the market is segmented into Pharmaceutical, Biotechnology Industry, Academics and Research, Environmental, Cosmetic Industry, and Food and Beverage.Based on geographies the market covered in this reports are North America, Europe Asia Pacific and Rest of the World. The major countries covered in this report are U.S., Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil.Read more: http://databridgemarketresearch.com/global-chromatography-solvents-market-expected-grow-cagr-10-1/The global players operating in this market are EMD-Millipore, Avantor Performance Materials, Tedia Company, Inc., Regis Technologies, Inc., Thermo Fisher Scientific, Inc., VWR International, and Qualikems Fine Chem Pvt. Ltd. among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research
News Article | July 12, 2017
-- Cures Within Reach, the leading global nonprofit organization focused on repurposing research as a fast track to saving patient lives, hosted its 5th Annual Global Health Repurposing Awards (GHRA) on June 27, 2017 at the Radisson Blu Aqua Hotel in Chicago, IL.Over 300 guests registered to attend this unique event, bringing together stakeholders from business, science, medicine, philanthropy, patient advocacy and media, who share a commitment to delivering treatments to patients quickly and affordably through repurposing. Chicago's ABC 7 Eyewitness News reporter and anchor Judy Hsu sevred as guest emcee for the evening. Prior to the event, Judy reported on a Cures Within Reach funded repurposing research project at the University of Illinois at Chicago that is helping patients suffering from chronic limb ischemia. (Link to the video at the bottom of this article.)More than $185,000 was raised to support the mission and programs of Cures Within Reach. The money was raised through a combination of sponsorships, event ticket purchases, a live auction and a paddle raise. This year, the GHRA had a record number of sponsorships. Since most repurposing treatments cost less than $250,000 to fund, the sponsors' participation in the GHRA can have a major impact on saving patients' lives."We are honored to have such strong sponsor support this year," said Dr. Bruce Bloom, President and Chief Science Officer at Cures Within Reach. "These partnerships allow us to celebrate our awardees and to continue our important work of advancing repurposing research as a way to drive treatments to patients who desperately need them."The 2017 GHRA sponsors include: Horizon Pharma plc (Premier Sponsor); Takeda Pharmaceuticals (Platinum Sponsor); American Landmark Properties, Goldman Philanthropic Partnerships, Integrated DNA Technologies, the Kahlert Foundation, Mindset Foundation (Legacy Sponsors); The Lockwood Group, Pep Marketing, PwC (Gold Sponsors); CBRE, Grund & Leavitt, Jazz Pharmaceuticals, Tonic Blue Communications, Vision for Tomorrow Foundation, Wilson Dow Group (Silver Sponsors); Aptinyx, Inc., Golan Christie Taglia, Healthcare Businesswomen's Association, the Judy Hirsch Foundation, Northwestern Mutual, TerSera Therapeutics LLC (Bronze Sponsors); Baxter Credit Union, BriovaRx, Cambridge BioMarketing, First Bank of Highland Park, PhRMA, Regis Technologies, Teva Pharmaceuticals, Zogenix, Inc. (Friend Sponsors).The 2017 GHRA had a rare disease focus in order to commemorate Cures Within Reach's first repurposing success, which found that the drug sirolimus created a life-saving treatment for a rare disease called autoimmune lymphoproliferative syndrome. Awards were given to leaders in business, science, medicine and philanthropy who have made a difference in patient lives through repurposing research that finds new uses for existing drugs, devices and nutraceuticals. This year's awardees were:• Timothy P. Walbert, Chairman, President and Chief Executive Officer of Horizon Pharma plc for Horizon's commitment to rare disease patients• Berish Rubin, PhD and Sylvia Anderson, PhD, Head and Director, Laboratory for Familial Dysautonomia Research, Fordham University for their work in repurposing nutriceuticals to treat Familial Dysautonomia• Dr. Michael Tranfaglia, Medical Director and Co-Founder of FRAXA Research Foundation for FRAXA's philanthropic investment in repurposing research to find a cure for fragile X syndrome• Dr. Lieven Lagae, Director of the Childhood Epilepsy Program at the KUL University Hospitals for his work in repurposing fenfluramine to treat Dravet syndromeThe 2018 Global Health Repurposing Awards will be held on June 26, 2018 and will have a cancer focus. To learn more about the work of Cures Within Reach, visit www.cureswithinreach.org.Chicago's ABC 7 Eyewitness News story on Cures Within Reach funded repurposing research project at the University of Illinois at Chicago: http://abc7chicago.com/ health/medical- treatment-repurpose... ABOUT CURES WITHIN REACHCures Within Reach works to catalyze repurposing research to quickly and affordably improve patient lives. We accomplish this by connecting funders with researchers to jumpstart repurposing research clinical trials, by providing collaboration tools so repurposing stakeholders can work together more easily, and by pioneering alternative finance engines and incentives for repurposing research. Cures Within Reach's repurposing research projects have generated over a dozen "new" treatments making patient impact through off-label use in clinical practice or through a commercialization track. Cures Within Reach currently has 24 repurposing research projects either funded or approved for funding.ABOUT CUREACCELERATOR™Cures Within Reach built CureAccelerator to provide a global collaboration space and marketplace for repurposing research that can deliver effective solutions to unsolved diseases. The CureAccelerator platform was built with a grant from the Robert Wood Johnson Foundation, to provide a platform in which drugs, devices and nutriceuticals approved for one or more human diseases can be repurposed to create "new" treatments in other diseases. CureAccelerator has over 1,000 users who have proposed 120 projects, of which more than 20 have received funding and are moving towards patient impact.Visit us at www.cureswithinreach.org or follow us via Twitter @CuresWReach, LinkedIn.com/company/cures-within-reach, YouTube.com/cureswithinreach or Facebook.com/CuresWithinReach.
News Article | July 18, 2017
— Chromatography Solvents Market By Type (Polar, Non Polar), By Technology (LCMS, HPLC, UHPLC), By Application (Analytical Chromatography, Preparative Chromatography), By End-User (Pharmaceutical, Biotechnology Industry, Academics and Research, Environmental, Cosmetic Industry, Food and Beverage), By Geography (North America, Europe, APAC, Latin America, MEA) Drivers: Some of the major factors driving the market for Chromatography Solvents Market are high emphasis being given to environmental testing, pollution control, food safety, drug development and other biotechnology driven research. Apart from this the increased funding in healthcare and government grants for food safety and environmental protection is fuelling the growth of this market. Patent Expiration: The biggest driver for the Chromatography Solvents Market is observed in the Biopharma industry. Patents of very successful drugs are expiring and many players want to step on this fruitful market, hence the development of biosimilars is booming. In particular, the strong development of diabetes treatment in the BRIC countries currently drives the big increase of insulin production, the purification of which is realized by chromatography. Chromatography technologies are well adapted for the purification of biosimilars since the use of semi-continous or continous chromatography increases the productivity drastically. For many diseases, catching and treating the disease in its early stage offers the optimal chance for a positive outcome. Some cancers can take months or years to appear, a time during which the disease may spread and significantly alter the prognosis and treatment. Among cancers specific to women, ovarian cancer is the leading cause of death in the U.S., according to the Ovarian Cancer National Alliance. More than 22,000 new cases of ovarian cancer are diagnosed annually. Ovarian cancer is often diagnosed in late stages, due to vague symptoms that mimic gastrointestinal disorders. Liquid chromatography (LC) has proved to be a boon for the life sciences and pharmaceuticals industries as it has the ability to segregate a wide variety of chemical mixtures applications such as drug development and quality assessment of pharmaceuticals and biopharmaceutical products have broadened the scope of LC applications, and has become the primary growth factor for this market. INCREASING USE OF CHROMATOGRAPHY IN PROTEOMICS: The proteomics market is growing due to factors such as the development of technologies that bridge the gap between genome sequence and cellular behavior, increasing R&D expenditure in the proteomics market, and increasing purchasing power of major research institutes due to the availability of funds from various organizations. Affinity chromatography is a powerful protein separation method that is based on the specific interaction between immobilized ligands and target proteins. It is considered to be the most selective chromatography technique to give the purest results and therefore is used in completing the protein purification process. Some of the major players operating in this market are • EMD-Millipore • Avantor Performance Materials • Tedia Company, Inc. • Regis Technologies, Inc. • Thermo Fisher Scientific, Inc. • VWR International • Qualikems Fine Chem Pvt. Ltd. Table Of Content: 1. INTRODUCTION 1.1. OVERVIEW OF THE CHROMATOGRAPHY SOLVENTS MARKET 1.2. MARKET SEGMENTATION & COVERAGE 2. RESEARCH METHODOLOGY 2.1. KEY TAKEAWAYS 2.2. ARRIVING AT THE CHROMATOGRAPHY SOLVENTS MARKET SIZE 2.2.1. .MARKET CRACKDOWN APPROACH 2.2.2. .COMPANY REVENUE AND MARKET SHARE ANALYSIS 2.2.3. .KEY DATA POINTS FROM PRIMARY SOURCE 2.2.4. KEY DATA POINTS FROM SECONDARY SOURCE 2.3. ASSUMPTIONS 3. MARKET LANDSCAPE SUMMARY 4. MARKET OVERVIEW 4.1. OVERVIEW 4.2. CHROMATOGRAPHY SOLVENTS MARKET: KEY PRIMARY INSIGHTS 4.3. DRIVERS, OPPORTUNITIES AND THREAT ANALYSIS MATRIX 4.4. KEY MARKET FINDINGS 4.5. NEW REGULATORY POLICIES 5. CHROMATOGRAPHY SOLVENTS MARKET, BY TYPE 5.1. OVERVIEW 5.2. POLAR SOLVENTS 5.3. NON-POLAR SOLVENTS 6. CHROMATOGRAPHY SOLVENTS MARKET, BY TECHNOLOGY 6.1. OVERVIEW 6.2. LCMS 6.3. HPLC 6.4. UHPLC 6.5. GCMS 6.6. OTHERS 7. CHROMATOGRAPHY SOLVENTS MARKET, BY APPLICATION 7.1. ANALYTICAL CHROMATOGRAPHY 7.2. PREPARATIVE CHROMATOGRAPHY 8. CHROMATOGRAPHY SOLVENTS MARKET, BY END-USER 8.1. PHARMACEUTICAL 8.2. BIOTECHNOLOGY INDUSTRY 8.3. ACADEMICS, RESEARCH AND GOVERNMENT INSTITUTES 8.4. ENVIRONMENTAL 8.5. COSMETIC INDUSTRY 8.6. FOOD AND BEVERAGE INDUSTRY 9. CHROMATOGRAPHY SOLVENTS MARKET, BY GEOGRAPHY 9.1. COUNTRYWISE CHROMATOGRAPHY SOLVENTS MARKET BY (TYPE, APPLICATION, TECHNOLOGY, END-USER) Related Report Asia-Pacific Chromatography Solvents Market – Trends and Forecast to 2024 Asia-Pacific Chromatography Solvents Market, By Type (Polar, Non Polar), By Technology (LCMS, HPLC, UHPLC), By Application (Analytical Chromatography, Preparative Chromatography), By End-User (Pharmaceutical, Biotechnology Industry, Academics and Research, Environmental, Cosmetic Industry, Food and Beverage), By Country (Japan, China, South Korea, India, Singapore, Australia, Rest of APAC) – Trends and Forecast to 2024 http://databridgemarketresearch.com/reports/medical-devices/chromatography-instruments/asia-pacific-chromatography-solvents-market/ About Data Bridge Market Research: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. For more information, please visit http://databridgemarketresearch.com/reports/global-chromatography-solvents-market/
Sciascera L.,University of Rome La Sapienza |
Ismail O.,University of Rome La Sapienza |
Ciogli A.,University of Rome La Sapienza |
Kotoni D.,University of Rome La Sapienza |
And 7 more authors.
Journal of Chromatography A | Year: 2015
With the aim of exploring the potential of ultra-fast chiral chromatography for high-throughput analysis, the new sub-2 micron Whelk-O 1 chiral stationary phase (CSP) has been employed in supercritical fluid conditions to screen 129 racemates, mainly of pharmaceutical interest. By using a 5-cm long column (0.46cm internal diameter), a single co-solvent (MeOH) and a 7-min gradient elution, 85% of acidic and neutral analytes considered in this work have been successfully resolved, with resolution (Rs) larger than 2 in more than 65% of cases. Moreover, almost a half of basic samples that, for their own characteristics, are known to be difficult to separate on Whelk-O 1 CSP, have shown Rs greater than 0.3. The screening of the entire library could be accomplished in less than 24h (single run) with 63% of positive score. For well-resolved enantiomers (Rs roughly included between 1 and 3), we show that method transfer from gradient to isocratic conditions is straightforward. In many cases, isocratic ultra-fast separations (with analysis time smaller than 60s) have been achieved by simply employing, as isocratic mobile phase, the eluent composition at which the second enantiomer was eluted in gradient mode. By considering the extension and variety of the library in terms of chemico-physical and structural properties of compounds and numerousness, we believe that this work demonstrates the real potential of the technique for high-throughput enantioselective screening. © 2015 Elsevier B.V.
PubMed | University of Rome La Sapienza, Regis Technologies Inc., University of Ferrara and University of Naples Federico II
Type: | Journal: Journal of chromatography. A | Year: 2015
With the aim of exploring the potential of ultra-fast chiral chromatography for high-throughput analysis, the new sub-2 micron Whelk-O 1 chiral stationary phase (CSP) has been employed in supercritical fluid conditions to screen 129 racemates, mainly of pharmaceutical interest. By using a 5-cm long column (0.46cm internal diameter), a single co-solvent (MeOH) and a 7-min gradient elution, 85% of acidic and neutral analytes considered in this work have been successfully resolved, with resolution (Rs) larger than 2 in more than 65% of cases. Moreover, almost a half of basic samples that, for their own characteristics, are known to be difficult to separate on Whelk-O 1 CSP, have shown Rs greater than 0.3. The screening of the entire library could be accomplished in less than 24h (single run) with 63% of positive score. For well-resolved enantiomers (Rs roughly included between 1 and 3), we show that method transfer from gradient to isocratic conditions is straightforward. In many cases, isocratic ultra-fast separations (with analysis time smaller than 60s) have been achieved by simply employing, as isocratic mobile phase, the eluent composition at which the second enantiomer was eluted in gradient mode. By considering the extension and variety of the library in terms of chemico-physical and structural properties of compounds and numerousness, we believe that this work demonstrates the real potential of the technique for high-throughput enantioselective screening.
Kotoni D.,University of Rome La Sapienza |
Ciogli A.,University of Rome La Sapienza |
Molinaro C.,University of Rome La Sapienza |
D'Acquarica I.,University of Rome La Sapienza |
And 5 more authors.
Analytical Chemistry | Year: 2012
A new chiral stationary phase for ultrahigh-pressure liquid chromatography (UHPLC) applications was prepared by covalent attachment of the Whelk-O1 selector to spherical, high-surface-area 1.7-μm porous silica particles. Columns of varying dimensions (lengths of 50, 75, 100, and 150 mm and internal diameters of 3.0 or 4.6 mm) were packed and characterized in terms of permeability, efficiency, retention, and enantioselectivity, using both organic and water-rich mobile phases. A conventional HPLC Whelk-O1 column based on 5.0-μm porous silica particles and packed in a 250 mm × 4.6 mm column was used as a reference. Van Deemter curves, generated with low-molecular-weight solutes on a 100 mm × 4.6 mm column packed with the 1.7-μm particles, showed Hmin (μm) and μopt (mm/s) values of 4.10 and 5.22 under normal-phase and 3.74 and 4.34 under reversed-phase elution conditions. The flat C term of the van Deemter curves observed with the 1.7-μm particles allowed the use of higher-than-optimal flow rates without significant efficiency loss. Kinetic plots constructed from van Deemter data confirmed the ability of the column packed with the 1.7-μm particles to afford subminute separations with good efficiency and its superior performances in the high-speed regime, compared to the column packed with 5.0-μm particles. Resolutions in the time scale of seconds were obtained using a 50-mm-long column in the normal phase or polar organic mode. The intrinsic kinetic performances of 1.7-μm silica particles are retained in the Whelk-O1 chiral stationary phase, clearly demonstrating the potentials of enantioselective UHPLC in terms of high speed, throughput, and resolution. © 2012 American Chemical Society.
Kotoni D.,University of Rome La Sapienza |
Ciogli A.,University of Rome La Sapienza |
D'Acquarica I.,University of Rome La Sapienza |
Kocergin J.,University of Rome La Sapienza |
And 4 more authors.
Journal of Chromatography A | Year: 2012
This paper reports on the thermodynamic and kinetic evaluation of a new ultra-high performance liquid chromatography broad-spectrum Pirkle-type chiral stationary phase (CSP) for enantioselective applications (eUHPLC). The well-known Whelk-O1 selector was covalently immobilized onto 1.7-μm high-surface-area, porous spherical silica particles to produce a totally synthetic, covalently bonded CSP that was packed into 150mm, 100mm, 75mm and 50mm columns, either 4.6 or 3.0mm ID. A 100mm×4.6mm ID column was fully characterized from a kinetic and thermodynamic point of view, using as reference a conventional HPLC Whelk-O1 column, 250mm×4.6mm ID, based on 5-μm porous silica particles. On the eUHPLC column, van Deemter plots generated Hmin values of 3.53μm for 1,3-dinitrobenzene, at an interstitial mobile phase linear velocity (μinter) of 5.07mm/s, and Hmin of 4.26 and 4.17μm for the two enantiomers of acenaphthenol, at μinter of 4.85mm/s and 4.24mm/s, respectively. Resolution of 21 enantiomeric pairs including alcohols, epoxides, sulfoxides, phosphine oxides, benzodiazepines and 2-aryloxyproprionic esters used as herbicides, were obtained with significant advantages in terms of efficiency and analysis time. Speed gain factors were calculated for the different column geometries (150mm, 100mm, 75mm and 50mm, either 4.6 or 3.0mm ID), with respect to the standard HPLC column (250mm×4.6mm ID), and were as high as 13, in the case of the 50-mm-long column, affording sub-minute separations of enantiomers with excellent resolution factors. In particular, trans-stilbene oxide was resolved in only 10s, while a 50mm×3.0mm ID column was used as a compromise between reduced mobile phase consumption (less than 1mL per analysis) and smaller extra-column band-broadening effect. Given the relatively low viscosity in NP mode, and the excellent permeability of these eUHPLC columns, with backpressure values under 600bar for a wide range of flow rates, the use of standard HPLC hardware is possible. In this case, however, a significant loss in resolution is observed, compared to the UHPLC instrumentation, if no modifications are introduced in the HPLC apparatus to reduce extra-column variance. The excellent efficiency and selectivity, conjugated with the very high-throughput and the ultra-fast analysis time, prove the potentials of the eUHPLC Whelk-O1 columns in the development of enantioselective UHPLC methods. © 2012 Elsevier B.V.
Cancelliere G.,University of Rome La Sapienza |
Ciogli A.,University of Rome La Sapienza |
D'Acquarica I.,University of Rome La Sapienza |
Gasparrini F.,University of Rome La Sapienza |
And 6 more authors.
Journal of Chromatography A | Year: 2010
Three brush-type chiral stationary phases (CSPs) differing in the particle size of the starting silica particles have been prepared by covalent grafting of the π-acidic bis-(3,5-dinitrobenzoyl)-derivative of trans-1,2-diaminocyclohexane (DACH-DNB). Starting silica particles of 4.3, 2.6 and 1.9 micron were used to generate the final CSPs using an improved, highly reproducible synthetic methodology, that allowed to assemble and surface-graft the whole chiral selector in only two steps. The different CSPs have been packed in columns of various length and diameters, and fully characterized in terms of flow permeability, kinetic performances and enantioselectivity using a set of test solutes. Very high speed and high resolution applications together with stereodynamic HPLC examples are demonstrated on the columns with reduced particle diameters, on which separations of several enantiomeric pairs are routinely obtained with analysis times in the 15-40 s range. © 2009 Elsevier B.V. All rights reserved.